Table 3.
Demographic patient data (age, BMI) and blood count (hemoglobin (Hb), platelet and leukocyte counts) of soft tissue sarcoma patients with and without a history of venous thromboembolism (VTE)
| G2 without a history of VTE (n = 5) | G2 with history of VTE (n = 3) | M1 without a history of VTE (n = 11) | M1 with history of VTE (n = 8) | All sarcoma patients without history of VTE (n = 28) | All sarcoma patients with history of VTE (n = 11) | Healthy controls (n = 17) | p-value of G2 patients with VTE vs controls | p-value of M1 patients with vs without VTE | p-value of all patients with VTE vs without VTE | |
|---|---|---|---|---|---|---|---|---|---|---|
| Age (years) | 69.4 ± 10.7 | 54.3 ± 3.9 | 56.8 ± 10.3 | 52.13 ± 14.4 | 58.1 ± 12.6 | 52.7 ± 12.4 | 48 ± 10.0 | 0.3179 | 0.4426 | 0.2460 |
| BMI (kg/m2) | 25.5 ± 2.5 | 23.3 ± 3.2 | 24.4 ± 4.2 | 24.3 ± 4.8 | 24.7 ± 3.6 | 24.1 ± 4.4 | 24.2 ± 3.4 | 0.7287 | 0.9756 | 0.6577 |
| Hb (g/dl) | 13.5 ± 0.9 | 10.5 ± 2.7 | 11.6 ± 1.6 | 12.7 ± 1.8 | 12.8 ± 1.8 | 12 ± 2.4 | 14,63 ± 1.0 | 0.0003 | 0.2561 | 0.3167 |
| Platelets (th/μl) | 256.0 ± 16.5 | 401.0 ± 150.1 | 254.0 ± 123.3 | 354.9 ± 144.4 | 261.8 ± 98.3 | 368.7 ± 147.7 | 227.3 ± 45.5 | 0.0018 | 0.1554 | 0.0186 |
| Leukocytes (th/μl) | 6.3 ± 1.0 | 9.5 ± 3.3 | 7.8 ± 6.5 | 7.9 ± 3.6 | 7.3 ± 4.3 | 8.4 ± 3.6 | 5.8 ± 1.2 | 0.0032 | 0.9773 | 0.4848 |
Data are presented as mean value ± standard deviation (SD). p-values were determined using Student’s t-tests for independent samples. p-values <0.05 are marked in bold